May 3, 2021 | Featured, Research News
FDA Approves Dapagliflozin (Farxiga) for Chronic Kidney Disease was reported by Susan Jeffrey for Medscape.com, 30 April 2021. The US Food and Drug Administration (FDA) has approved dapagliflozin (Farxiga, AstraZeneca) to reduce the risk for...
Apr 26, 2021 | Featured, Research News, Technology Updates, Videos
A Real-World Prospective Study of the Safety and Effectiveness of the Loop Open Source Automated Insulin Delivery System was published on Liebertpub.com, 12 April 2021. This is a very exciting and important study, validating the effectiveness and safety of those...
Apr 19, 2021 | Featured, Research News, Technology Updates
FDA grants breakthrough therapy designation for novel type 1 diabetes pill was reported by Regina Schaffer for Healio.com/endocrinology, 14 April 2021. The FDA granted breakthrough therapy designation for TTP399 as an adjunctive therapy to insulin for the...
Apr 14, 2021 | Featured, Research News, Technology Updates
The Loop and Learn T1D Speakers series hosted the 3 founders of Digital Diabetes Analytics, all the way from Sweden. It was a very interesting presentation, about their work to develop algorithms for machine learning, based on CGM data, for their current...
Apr 12, 2021 | Featured, Research News, Stories of D Life
Experimental oral pills auto-release insulin when glucose levels are high was reported by Michael Irving for NewAtlas.com/medical, 7 April 2021. Researchers at NYU Abu Dhabi have developed a system that can do just that. The team created what they call...
Apr 5, 2021 | Featured, Research News, Stories of D Life
Here’s an interview by Monica Westley, of TheSugarScience, with Dr. Hans Sollinger, MD, PhD, Founder & Interim CSO of Endsulin. Dr. Sollinger has been a leader in diabetes care for decades and has revolutionized the field twice. Endsulin is...